Detalles de la búsqueda
1.
Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study.
Eur J Neurol
; 31(7): e16292, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587143
2.
Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease: An experience from the French Pompe Registry.
Mol Genet Metab
; 139(3): 107611, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285781
3.
A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases.
Orphanet J Rare Dis
; 16(1): 450, 2021 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34702344
4.
LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2.
Eur J Hum Genet
; 27(9): 1406-1418, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30996334
Resultados
1 -
4
de 4
1
Próxima >
>>